Clinical Trial Update: Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating induction chemotherapy with FOLFOXIRI plus cetuximab in unresectable/metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFOXIRI regimen (FOLFOXIRI)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED